Methods for preparing d-threo-methylphenidate using diazomethane, and compositions thereof
View Patent ↗Novel methods and systems for producing a substantially pure d-threo stereoisomer of methylphenidate or a salt thereof are provided. In particular, methods and systems for producing d-threo-methylphenidate hydrochloride in pure stereoisomeric form from d-threo-ritalinic acid hydrochloride using diazomethane are described. The described methods can be performed on a large scale, and thus provide d-threo methylphenidate or a salt thereof, and particularly the hydrochloride salt of d-threo-methylphenidate, in stereoisomerically pure form and in large quantities from a single batch reaction. Also described are novel compositions of d-threo methylphenidate hydrochloride.
1. A composition comprising substantially pure d-threo-methylphenidate hydrochloride and an N-methyl species of d-threo-methylphenidate hydrochloride having the formula (III):
wherein R 1 represents phenyl.
2. The composition according to claim 1 , wherein the N-methyl species is present in an amount that is about 8% area or less based on peak area of a peak corresponding to the N-methyl species as determined by high performance liquid chromatography (HPLC) analysis relative to a total of 100% area based on peak area of peaks corresponding to the substantially pure d-threo-methylphenidate hydrochloride and N-methyl species thereof as determined by HPLC analysis.
3. The composition according to claim 2 , wherein the N-methyl species is present in an amount that is about 5% area or less based on the peak area of the peak corresponding to the N-methyl species.
4. The composition according to claim 2 , wherein the N-methyl species is present in an amount that is no more than 0.10% area based on the peak area of the peak corresponding to the N-methyl species.
5. The composition according to claim 1 , wherein the N-methyl species is present in an amount ranging from about 0.001% area to about 8% area based on the peak area of the peak corresponding to the N-methyl species.
6. A composition comprising substantially pure d-threo-methylphenidate hydrochloride and an N-methyl species of d-threo-methylphenidate hydrochloride having the formula (III):
wherein the substantially pure d-threo-methylphenidate hydrochloride and the N-methyl species of d-threo-methylphenidate hydrochloride are obtained by a method comprising:
(i) obtaining a first solution comprising an aqueous solution of an inorganic base and a water miscible solvent;
(ii) obtaining a second solution comprising an N-methyl-N-nitroso amine of formula (IV):
in a water immiscible organic solvent;
(iii) adding the second solution to the first solution, thereby generating diazomethane; and
(iv) reacting substantially pure d-threo-ritalinic acid hydrochloride with the diazomethane generated in step (iii) for at least about five hours to obtain the substantially pure d-threo-methylphenidate hydrochloride, wherein the reaction is performed at a temperature of about −20° C. to about 10° C., and a molar ratio of diazomethane to the substantially pure d-threo stereoisomer of ritalinic acid hydrochloride is about 4 to 9, and
wherein R 1 represents phenyl;
R 2 represents a member selected from the group consisting of:
R 3 represents a hydrogen atom, an alkyl group having one to four carbon atoms, or a nitro group;
and R 4 represents a hydrogen atom or an alkyl group having one to four carbon atoms.
7. The composition according to claim 6 , wherein the N-methyl species is present in an amount that is about 8% area or less based on peak area of a peak corresponding to the N-methyl species as determined by high performance liquid chromatography (HPLC) analysis relative to a total of 100% area based on peak area of peaks corresponding to the substantially pure d-threo-methylphenidate hydrochloride and N-methyl species thereof as determined by HPLC analysis.
8. The composition according to claim 7 , wherein the N-methyl species is present in an amount that is about 5% area or less based on the peak area of the peak corresponding to the N-methyl species.
9. The composition according to claim 7 , wherein the N-methyl species is present in an amount that is no more than 0.1% area based on the peak area of the peak corresponding to the N-methyl species.
10. The composition according to claim 6 , wherein the N-methyl species is present in an amount ranging from about 0.001% area to about 8% area based on the peak area of the peak corresponding to the N-methyl species.
11. A system for producing the composition of claim 6 , the system comprising:
(i) a reaction chamber comprising:
(a) a generator portion comprising an inlet, and holding the first solution comprising the aqueous solution of the inorganic base and the water miscible solvent, and
(b) a receiver portion connected to the generator portion by a condenser, the receiver portion holding the substantially pure d-threo-ritalinic acid hydrochloride; and
(ii) the second solution comprising the N-methyl-N-nitroso amine of formula (IV):
in the water immiscible organic solvent,
wherein the generator portion is maintained at a temperature sufficient to vaporize the organic solvent and the diazomethane generated upon introduction of the second solution into the generator portion via the inlet, and the receiver portion receives the vaporized diazomethane and the receiver is maintained at the temperature of about −20° C. to about 10° C. for at least about five hours to obtain the substantially pure d-threo-methylphenidate hydrochloride.
12. A composition comprising substantially pure d-threo-methylphenidate hydrochloride and an N-methyl species of d-threo-methylphenidate hydrochloride having the formula (III):
wherein the N-methyl species is present in an amount ranging from about 0.001% area to 0.10% area based on peak area of a peak corresponding to the N-methyl species as determined by high performance liquid chromatography (HPLC) analysis relative to a total of 100% area based on peak area of peaks corresponding to the substantially pure d-threo-methylphenidate hydrochloride and N-methyl species thereof as determined by HPLC analysis, and wherein R 1 represents phenyl.
13. The composition according to claim 12 , wherein the substantially pure d-threo-methylphenidate hydrochloride and the N-methyl species of d-threo-methylphenidate hydrochloride are obtained by a method comprising:
(i) obtaining a first solution comprising an aqueous solution of an inorganic base and a water miscible solvent;
(ii) obtaining a second solution comprising an N-methyl-N-nitroso amine of formula (IV):
in a water immiscible organic solvent;
(iii) adding the second solution to the first solution, thereby generating diazomethane; and
(iv) reacting substantially pure d-threo-ritalinic acid hydrochloride with the diazomethane generated in step (iii) for at least about five hours to obtain the substantially pure d-threo-methylphenidate hydrochloride,
wherein the reaction is performed at a temperature of about −20° C. to about 10° C., and a molar ratio of diazomethane to the substantially pure d-threo stereoisomer of ritalinic acid hydrochloride is about 4 to 9, and
wherein R 2 represents a member selected from the group consisting of
R 3 represents a hydrogen atom, an alkyl group having one to four carbon atoms, or a nitro group;
and R 4 represents a hydrogen atom or an alkyl group having one to four carbon atoms.